Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasms × Drug Delivery Systems × Clear all

Phase

Status

Sponsor Class

INDUSTRY 4 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Pancreatic Cyst 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Mouth Neoplasms 1 Medication Adherence 1 Margins of Excision 1 Lymphoma, Follicular 1 Lymphedema 1 Liver Neoplasms 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Glioblastoma 1 Early-stage Peripheral Non-small Cell Lung Cancer 1 Depression 1 Dementia 1 Cognitive Dysfunction 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Neoplasms 1 Breast Cancer Female 1 Anxiety Disorders 1 Alzheimer Disease 1

Interventions

Surveys and Questionnaires 93 Exercise 84 Blood Specimen Collection 75 Radiotherapy 59 Gemcitabine 49 Standard of Care 48 Bevacizumab 48 Cisplatin 47 Carboplatin 43 Dexamethasone 42 Capecitabine 41 Paclitaxel 39 Cyclophosphamide 39 Interviews as Topic 38 pembrolizumab 37 Docetaxel 37 Oxaliplatin 34 Methods 33 Magnetic Resonance Spectroscopy 32 Irinotecan 32 Fluorouracil 32 Therapeutics 27 Radiosurgery 25 Nivolumab 25 Drug Therapy 25 Educational Status 23 Leucovorin 20 Surgical Procedures, Operative 19 Everolimus 19 Erlotinib Hydrochloride 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04667689 2024-04-01

CAMPFIRE

University of Rochester

Phase NA Completed

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡